Is Nektar Therapeutics (NKTR) a Buy, Sell, or Hold?
NASDAQ : NKTR
Nektar Therapeutics — Competitors
$70.77 USD
-$0.58 (-0.81%)
- Volume
- 713.17K
- Average Volume
- 1.03M
- Market Capitalization
- $1.38B
- P/E Ratio
- -8.40
- Dividend Yield
- 0.00%
- Price Target
- $152.00
- Year High
- $109.00
- Year Low
- $21.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.21
NKTR vs. The Competition
| Properties | NKTR | AMLX | ATAI | ELVN |
|---|---|---|---|---|
| Market Cap | $1.38B | $2.17B | $2.66B | $3.84B |
| Shares Outstanding | $19.54M | $111.19M | $369.95M | $71.44M |
| P/E Ratio | -8.4 | -13.21 | -2.39 | -32.78 |
| EPS | -6.39 | -1.36 | -2.93 | -1.57 |
| Day Low | 68.73 | 18.905 | 7.15 | 52 |
| Day High | 72 | 19.99 | 7.1966 | 54.12 |
| Year Low | 21.02 | 7.48 | 3.265 | 14.785 |
| Year High | 109 | 19.99 | 7.22 | 55.79 |
| Average Price 50 | 65.729 | 15.8661 | 4.9296 | 45.5053 |
| Average Price 200 | 62.72935 | 14.7148 | 4.37673 | 32.1402 |
| Volume | 713.17K | 2.87M | 17.21M | 727.22K |
| Average Volume | - | - | - | - |